Sobi to present new Aspaveli/Empaveli data at ASN Kidney Week 2026 (Yahoo Finance) - Oct 19, 2026 - "The programme includes two oral and five poster presentations covering longer-term clinical outcomes, renal safety and treatment experience, alongside the phase IV PRISM-C3 study, reflecting Sobi's commitment to generating real-world evidence...These include a paediatric subgroup analysis from VALIANT and its VALE extension."
P3 data • P4 data • Real-world • Glomerulonephritis • Paroxysmal Nocturnal Hemoglobinuria
|